[Curative effect of interferon-alpha on rat liver fibrosis induced by CCl4]
- PMID: 19001734
[Curative effect of interferon-alpha on rat liver fibrosis induced by CCl4]
Abstract
Objective: To explore the curative effect and the mechanism of interferon-alpha (IFN-alpha) on rat liver fibrosis induced by CCl4.
Methods: Thirty-nine male SD rats were randomly divided into 3 groups. The rats in the normal control group (n=10) received subcutaneous injection of peanut oil (0.003 mL/g body weight) for 10 weeks. Rat liver fibrosis was induced in 29 rats by 0.003 mL/g subcutaneous injection of 40% CCl4 (CCl4: peanut oil = 2:3), twice weekly for 10 weeks. In the 7th week, these 29 rats were randomly divided into a liver fibrosis group without treatment (n=15) and an IFN-alpha treatment group (n=14), which received subcutaneous injection of IFN-alpha-2b at 10(6) units per rat. The rats' liver tissue was collected and HE and Masson staining were performed to observe of pathological changes, stage of liver fibrosis,and semi-quantitative scoring. Immunohistochemistry was used to detect the expression of Collagen I, alpha-smooth muscle actin (alpha-SMA),and transforming growth factor-beta1 (TGF-beta1) in the rat liver.
Results: The stage of liver fibrosis, semi-quantitative scoring of Masson staining, and immunohistochemical staining of Collagen I in the liver fibrosis group were significantly higher than those of the normal controls (All P<0.01), and those in the IFN-alpha treatment group were significantly lower than those of the liver fibrosis group(P<0.05). The semi-quantitative immunohistochemical scoring of alpha-SMA and TGF-beta1 in the liver fibrosis group was significantly higher than those of the normal control (All P<0.01), and that in the IFN-alpha treatment group was significantly lower than that of the liver fibrosis group (All P<0.05).
Conclusion: Treatment of IFN-alpha can decrease the liver fibrogenesis induced by CCl4 in rats. The anti-fibrosis effect of IFN-alpha may be attributed to the inhibition of the hepatic stellate cells' activation to decrease TGF-beta1 expression.
Similar articles
-
Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice.Hepatobiliary Pancreat Dis Int. 2009 Jun;8(3):300-8. Hepatobiliary Pancreat Dis Int. 2009. PMID: 19502172
-
[Effect of interferon-α on rat liver fibrosis induced by CCl(4)].Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2011 Mar;36(3):243-8. doi: 10.3969/j.issn.1672-7347.2011.03.009. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2011. PMID: 21464546 Chinese.
-
[Therapeutic effects of octreotide on hepatofibrosis-induced with carbon tetrachloride in rats].Zhonghua Gan Zang Bing Za Zhi. 2003 Jul;11(7):408-11. Zhonghua Gan Zang Bing Za Zhi. 2003. PMID: 12890342 Chinese.
-
[The effect of D-penicillamine on experimental liver cirrhosis induced by CCl4].Morphol Igazsagugyi Orv Sz. 1990 Jul;30(3):161-9. Morphol Igazsagugyi Orv Sz. 1990. PMID: 2233769 Review. Hungarian.
-
Prevention and treatment of liver fibrosis based on pathogenesis.Alcohol Clin Exp Res. 1999 May;23(5):944-9. Alcohol Clin Exp Res. 1999. PMID: 10371420 Review.
Cited by
-
CD4+CD25+Foxp3+ regulatory T cells contribute in liver fibrosis improvement with interferon alpha.Inflammation. 2013 Dec;36(6):1374-82. doi: 10.1007/s10753-013-9677-0. Inflammation. 2013. PMID: 23813328